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Abstract
Background: Mothers with diabetes are less likely to achieve successful breastfeeding. Antenatal breastmilk
expression (ABE) may facilitate earlier breastfeeding, but feasibility of introducing ABE and its acceptance among
Scandinavian women have previously not been investigated.
Methods: This observational trial was conducted between the 1 January 2019 and the 12 March 2020 in Tromsø,
Norway. We aimed to determine the feasibility of ABE in terms of practicality and acceptability among women with
medically (metformin or insulin) treated diabetes. Women were invited to participate during antenatal visits from
32 weeks gestation. Participants received instruction and started ABE from gestation week 37 + 0. Participants, and
their infants, were followed until 6–8 weeks after birth. We collected data on breastfeeding rates, infant hypoglycemia,
transfer to the neonatal unit, and the women’s overall experience and satisfaction with antenatal breastmilk expression.
Results: Twenty-eight of 34 (82%) invited women consented to participate. All started ABE from week 37 + 0, and
continued until hospital admission. No women reported any discomfort or side effects. Labor was induced at 38 weeks
gestation. Twenty-four women brought harvested colostrum to the maternity ward, which was given to their infants
during the first 24 h of life. Breastfeeding rates at discharge were 24/28 (86%) and 21/27 (78%) at 6–8 weeks after
delivery. Seven (25%) infants were transferred to the neonatal unit; four because of hypoglycemia. Maternal satisfaction
assessed 6–8 weeks after delivery revealed that all participants felt positive about the ABE, but one woman would not
recommend it to other pregnant women.
Conclusions: Implementing a structured ABE guideline for women with medically treated diabetes was feasible. The
intervention was associated with high level of satisfaction among study participants. No obvious side effects were
observed, and breastfeeding rates at discharge and 6–8 weeks after delivery were higher than in comparable studies.
Trial registration: The study was registered at the research study registry at the University Hospital of North Norway
(Nr 2018/7181).
Keywords: Pregnancy, women’s satisfaction, women’s experience, Breastfeeding, Newborn, Infant, Hypoglycemia,
Expressed breast milk, Diabetes, Antenatal period
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Background
Mothers with diabetes are less likely to achieve success-
ful breastfeeding than mothers without diabetes [1–3].
They have delayed onset of lactation and delivery is
often before term due to planned induction. If induction
fails there is an increased risk of cesarean section (CS)
[4, 5]. Infants of mothers with diabetes are at risk of
hypoglycemia due to fetal-neonatal hyperinsulinism.
Maternal-child separation after CS or transfer of the in-
fant to a neonatal intensive care unit (NICU) due to
hypoglycemia, further decreases the chances of establish-
ing successful breastfeeding [6]. Early provision of infant
formula is therefore relatively common in this group of
infants, and is generally associated with a shorter time of
exclusive breastfeeding [7]. The mother’s own colostrum,
is optimal to facilitate the metabolic transition after birth
and stabilizes infant glucose concentration more effect-
ively than infant formula [8]. Breastfeeding has numerous
benefits including preventing infants from becoming over-
weight and preventing the development of established dia-
betes in the mother and the child later in life [9, 10]. In
Norway, 89% of all mothers, report that they are breast-
feeding (74% exclusively) 8 weeks after birth. Thus, there
are clear expectations among pregnant women in Norway
that they should breastfeed after birth [11].
Antenatal breastmilk expression (ABE) is the hand ex-
pression and collection of colostrum during pregnancy.
The benefit of ABE is to have a supply of colostrum for
these infants at risk of hypoglycemia whose mothers are
at risk of delayed lactogenesis in order to avoid the use
of infant formula [1]. It has been studied and imple-
mented as routine care in Australia and New Zealand in
order to avoid using infant formula and facilitate earlier
breastfeeding [12, 13]. In contrast, albeit being sporadic-
ally suggested, ABE is not widely recommended nor
studied in Europe, except from in the UK [14]. In our
hospital, we experienced that women with diabetes be-
came aware of ABE through the internet or other
sources and requested support for this practice. There-
fore, we decided to conduct an observational pilot study
to assess the feasibility of introducing a clinical guideline
for ABE for pregnant women with diabetes. The primary
outcome was maternal satisfaction and breastfeeding
rates, both at hospital discharge and 6 to 8 weeks after
birth. Secondary outcomes were number of infants given
harvested colostrum during the first 24 h of life, infant
hypoglycemia and NICU admission rates.
Methods
Setting and study design
This study was performed in the tertiary care obstetric
department at the University Hospital of Northern
Norway, Tromsø, Norway. Within the hospital’s catch-
ment area there around 2000 births per year, in three
hospital locations. Pregnant women with medically
treated diabetes mellitus are advised to give birth only at
the tertiary care unit in Tromsø. During the study
period, pregnant women with diabetes were routinely
admitted to the labor ward at gestational week 38 + 0. If
there were no signs of spontaneous labor, induction was
initiated with a cervical ripening balloon catheter.
From 1 January 2019, women with diabetes mellitus in
need of medication and with a singleton pregnancy were
eligible for inclusion in the study. Exclusion criteria were
a history of previous preterm birth, antepartum
hemorrhage or placenta previa. Women identified as eli-
gible received an invitation to participate during routine
antenatal visits from 32 weeks gestation.
Women who consented to participate attended a con-
sultation with one of the project-midwives (MJ, GA,
MB) 2–3 weeks before hospital admission for birth in-
duction. During this consultation, the women received
practical training in the form of a single session lasting
around 1 h. Information leaflets and videos explaining
how to perform ABE were provided. The women were
given a package with small medicine cups, 2- and 5-ml
syringes with stoppers, barcodes and zip bags for storing
colostrum. They were informed about good hand hy-
giene and how to store colostrum safely in their home
freezers until hospital admission.
The women were encouraged to stimulate and hand
express colostrum three to five times daily for at least 10
min, starting from 37 + 0 week. If they experienced any
discomfort, in particular uterine contractions, or had any
questions about the intervention, they were asked to
contact one of the midwives in the project. The women
brought the frozen colostrum to the hospital when they
were admitted for induction and/or delivery. The colos-
trum was stored in a freezer at the postnatal ward,
thawed to room temperature in a cup with warm
water and given to their infant during the first 24 h
after birth.
For infants born to mothers with diabetes the follow-
ing routine care was applied; early skin-to-skin contact
and breastfeeding as the first meal within the first hour
after birth, when possible. The first blood sugar was rou-
tinely obtained around 2 h after birth, or earlier if
hypoglycemia symptoms occurred. Target blood sugar
values were > 2.0 mmol/L in the first 24 h and thereafter
> 2.6 mmol/L. All infants with blood sugar < 1.4 mmol/l
were transferred to the NICU. If blood sugar was be-
tween 1.4–1.9 mmol/L infants were first given 5–10 ml
expressed milk, pasteurized donor milk or formula from
a cup. The blood sugar level was subsequently moni-
tored at least three times during the first 24 h after birth.
When stable values > 2.6 mmol/L were reached, moni-
toring was discontinued and normal postnatal routines
with self-regulation continued.
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We recorded rates of breastfeeding, both exclusive and
partial since birth, at hospital discharge and 6–8 weeks
after delivery, when the women were interviewed tele-
phonically. This interview also included two questions,
that were rated on a 5-point Likert scale; i) how women
had perceived participating in the ABE-project and ii)
whether they would recommend ABE to other women.
Participants were also given the opportunity to comment
openly on the intervention and their experience with
antenatal breastmilk expression.
Data collection, sample size and statistical analyses
Data was collected from the birthplace computer system
“Partus” (Clinsoft: Clinical software, Oslo, Norway). No
formal sample size calculation was performed for this
feasibility study, but we aimed to recruit a convenience
sample of 40 women. We had to stop the recruitment
on 12 March 2020 when all clinical trials in our hospitals
were put on hold due to the COVID-19 outbreak. Cat-
egorical data are displayed as number and frequency (%)
and continuous data as mean and standard deviation
(SD). Data were analyzed using IBM-SPSS (version 26)
statistical software.
Trial registration and ethical approval
The study was registered at the research study registry
at the University Hospital of Northern Norway (Nr
2018/7181), and approved by the Regional Ethics Com-
mittee (2018/1679 REK Nord).
Results
During the 14-month study period we invited 34 eligible
women and 28 (82%) consented to participate. Clinical
data on the mothers and their infants are presented in
Table 1. Around two-thirds of the women were nullipar-
ous. The majority had a body mass index above 25 kg/
m2. Twenty-one participants (75%) had gestational dia-
betes, treated with metformin or insulin. Mean birth-
weight of infants in our study was 3349 g, which is
between the 25-50th centile for babies born in week 38
in Norway. Most infants had normal Apgar scores. In
four out of 28 infants, the first blood sugar was below
1.4 mmol/l (Table 1).
All of the women started ABE from week 37 + 0, and
continued until hospital admission. None of the partici-
pants reported any discomfort or side effects. Two
women contacted the project midwives one time, and re-
quested further advice in regards to the practice of ante-
natal breastmilk expression. Maternal satisfaction was
assessed 6–8 weeks after delivery in 27 of 28 partici-
pants; one woman was lost to follow-up. At this time all
participants (100%) were positive to the practice of ABE,
and 26/27 (96%) would recommend ABE to other preg-
nant women. In the open-ended question, the vast
majority stated that participating in the study and per-
forming ABE was a very positive experience (detailed
data not shown). The single woman who did not want to
recommend ABE to other mothers perceived ABE as
“too laborious”.
Figure 1 shows the flow of the 28 study participants
and their infants. Twenty-four women (86%) brought
harvested colostrum to the maternity ward. One woman
forgot the colostrum at home, and three women stimu-
lated the breasts at home but did not harvest any colos-
trum. Twenty-four of the 28 infants were breastfed as
the first meal after birth. Thirteen infants were also
given mean (range) 3 (1–7) ml harvested colostrum as
supplement after the first breastfeeding meal. The har-
vested colostrum was subsequently given to all 24 in-
fants during the first 24 h at different times, when the
mother and the midwife felt it was needed to supple-
ment after breastfeeding. Six to eight weeks after deliv-
ery 21/27 (78%) mothers were exclusively or partially
breastfeeding (Fig. 1). The breastfeeding rate among
Table 1 Clinical data on 28 mothers with medically treated
diabetes (metformin or insulin), and their infants
Mothers
Age, years 31.4 (7.1)
Age (range), years 20–45
Parity
Para 0 18/28 (64)
Para 1+ 10/28 (36)
Body mass index (kg/m2) X 30.9 (8.8)
Body mass index > 25 kg/m2 21/28 (75)
Diabetes mellitus
Type 1 3 (11)
Type 2 4 (14)
Gestational 21 (75)
Labor
Labor induction 22/28 (79)
Age induction (gestational week) 38 (0.7)
Vaginal: caesarean delivery 18: 10
Infants
Birthweight, grams 3349 (484)
Apgar score-5 min≥ 7 25/28 (89)
Blood sugar
First blood sugar (mmol/L) 2.9 (1.4)
First blood sugar < 1.4 mmol/L 4/28 (14)
Second blood sugar (mmol/L) 3.4 (0.8)
Third blood sugar (mmol/L) 3.5 (0.8)
Admission neonatal unit 7/28 (25)
All values are mean (standard deviation) or number and percentage (%)
X Body mass index at first antenatal consultation
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those admitted to the NICU was 100% at later follow-
up.
Discussion
In this study we have shown that most pregnant women
with diabetes who received training in ABE 2 to 3 weeks
before admission to the maternity unit were able to pro-
duce and harvest colostrum. No adverse effects were re-
ported, in particular no signs of preterm contraction.
Most women breastfed upon hospital discharge and also
6–8 weeks after delivery. Participants were positive to-
wards ABE and the intervention, and they would recom-
mend it to other pregnant women with diabetes.
Antenatal breastmilk expression thus shows promise of
being successful in this population who often face chal-
lenges associated with establishing breastfeeding. More-
over, ABE is a simple and well-accepted method to
increases maternal skills.
One concern about ABE is that an oxytocin release
could potentially lead to early onset of labor. None of
the participants in this study reported any contractions
related to antenatal breastmilk expression. Other reports
have also suggested that there is no harm in advising
women to express their own milk before labor and no
uterine hyperstimulation was observed [12, 15]. An ex-
planation may be that in a normal pregnancy, the uter-
ine sensitivity to oxytocin and the level of oxytocin
receptor level in the myometrium increase up at full-
term and are not activated earlier [16]. It is also known
that in a normal pregnancy, intercourse or breastfeeding
an older sibling is not contraindicated, although oxyto-
cin is also released in these situations [17, 18].
Women with diabetes often feel a higher emotional
stress compared to the healthy mothers, and sometimes
their concern is exacerbated by healthcare workers [19].
They may also experience guilt and stress, considering
the added risk of hypoglycemia to their infant [20]. Ma-
ternal empowerment is an important aspect of perinatal
care and breastfeeding support [21]. Initiating ABE may
empower the woman and subsequently increase her
chance for successful breastfeeding and reduce the risk
of infant hypoglycemia. We were motivated to do this
study after we received requests regarding ABE from
many pregnant women. Interviews with the participants
Fig. 1 Flow chart – Women with diabetes who started antenatal breast milk expression around 1 week before delivery (n = 28) and their infants.
XOne woman and her infant was lost to follow-up at 6–8 weeks after delivery
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indicated a high level of maternal satisfaction with the
intervention. In a UK study, women with obesity who
were informed about ABE also found it helpful to pre-
pare for breastfeeding [14]. Moreover, the intervention is
in line with the “Ten steps to successful breastfeeding”,
as defined by the WHO and UNICEF [22], and supports
the nursing staff’s aim to empower mothers and enable
breastfeeding.
An important goal of this study, was to promote and
support breastfeeding after birth among women with
diabetes, since they are at increased risk for a delayed
lactation. Our results show that 24 of the 28 women
breastfed upon discharge and 21/27 (78%) were still
breastfeeding 6 to 8 weeks after birth. This is a high rate
of breastfeeding among women with diabetes compared
to earlier studies, where only around 30–60% of women
were breastfeeding at discharge or 6 weeks later [2, 3].
Unfortunately, we do not have Norwegian data on
breastfeedng for this specific population. Still, we believe
that prenatal education of ABE increased the awareness
of delayed lactogenesis among mothers with diabetes in
our study, which motivated these women to continue
breastfeeding despite initial challenges. Earlier studies
also point out that women with diabetes who started
ABE were physically and mentally better prepared for
breastfeeding than those who did not [23].
In this feasibility study seven (25%) infants were ad-
mitted to NICU after birth, but only four due to
hypoglycemia. It is worth noting that all second and
third blood sugar values obtained from infants in this
study were normal during the first 24 h. Our study is
small and not powered to assess rates of hypoglycemia
or NICU admission. In the large Diabetes and Antenatal
Milk Expressing (DAME) multicenter, randomized con-
trolled trial (RCT), the proportion of infants admitted to
NICU was lower than in our study, but did not differ be-
tween groups assigned to ABE or standard care [12]. We
observed that women brought small volumes of colos-
trum after performing ABE for only around 1 week.
DAME study participants started expressing in week 36,
1 week earlier than in our study. In New Zealand they
usually advise women to start expressing milk from week
34 [12]. Our results support the notion that it is prob-
ably beneficial to start ABE earlier than week 37.
The strengths of this study were the structured ap-
proach to ABE. The participants expressed a high degree
of satisfaction, and the overall breastfeeding rate was high.
The main limitation of this study is that is it not a RCT.
The low numbers of participants, exaggerated by early
study termination due to the COVID-19 pandemic, pre-
cludes strong conclusions regarding infant hypoglycemia
and NICU admission rates. Accurate volumes of harvested
colostrum were not recorded, but the stimulation of breast
milk production before birth may be the most important
component of ABE contributing to facilitate breastfeeding
shortly after birth. The women were highly satisfied with
their inclusion in this ABE study, but this could also be
part of the Hawthorne effect, that the study participants
feel better because they receive more attention than rou-
tine care [24].
Conclusions
We found that implementing a structured ABE guideline
for women with medically treated diabetes was feasible
and associated with high level of satisfaction among
study participants. No obvious side effects were ob-
served, breastfeeding rates at discharge and 6–8 weeks
after birth were higher than in comparable studies.
Antenatal breastmilk expression may lead to increased
maternal empowerment and increased breastfeeding
rates among women with diabetes or other women with
known challenges in establishing breastfeeding. Well-
designed, and adequately powered RCTs with appropri-
ate outcomes, including user perspective data, are
needed to define the role of ABE in future perinatal
care.
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